Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
Launched by MEMORIAL SLOAN KETTERING CANCER CENTER ·
Trial Information
Current as of September 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called Family COMIDA, is studying the best way to help Hispanic families work together to support healthy eating and weight loss, especially for children facing obesity. The goal is to find a family-centered program where parents and caregivers play an active role in encouraging healthy habits to prevent or reduce obesity.
The study is open to people of all genders, and it focuses on families with children between the ages of 6 and 74 (likely a typo, but usually this means children and possibly their adult caregivers). If you join, you and your family will participate in a program designed to promote better food choices and healthier lifestyles. This could be a good opportunity for families wanting support in making lasting healthy changes together. The trial is currently recruiting participants, so families interested in improving their health through teamwork are encouraged to learn more.
Gender
ALL
Eligibility criteria
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jennifer Leng, MD, MPH
Principal Investigator
Memorial Sloan Kettering Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported